MedPath

Single Dose of Dexamethasone in Femur Fractures

Phase 4
Conditions
Fractured Neck of Femur
Interventions
Registration Number
NCT01550146
Lead Sponsor
Cork University Hospital
Brief Summary

Fracture neck of femur is a common cause of hospital admission in the elderly and requires operative fixation.

Dexamethasone has the potential of inhibiting cortisol secretion. In addition, preoperative glucocorticoids improve analgesia and decrease opioid consumption with reduction in associated side effects in a variety of clinical settings.

The investigators hypothesis was that a single dose of preoperative dexamethasone enhance postoperative analgesia and attenuates the inflammatory response in patients undergoing operative fixation of fractured neck of femur, in a prospective, randomized, placebo controled trial.

Detailed Description

Having obtained ethical approval and written informed consent from each, 40 patients scheduled to undergo operative fixation of fractured neck of femur will be randomized using sealed envelopes to two groups.

Patients in the Dexamethasone group receive a single dose of 0.1 mg/kg dexamethasone iv. preoperative, patients in the Placebo group receive the same amount of Normal Saline. The anaesthetic technique is standardized, salive samples, blood samples are taken and pain scores are measured on a visual analog scale postoperatively at several timepoints.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • above 65 years
  • ASA I-III patients
Exclusion Criteria
  • patient refusal
  • outside age range
  • coagulation disorders
  • depression
  • Cushing syndrome
  • endocrine disorders
  • corticosteroid treatment in the last 4 month
  • head injury or associated injuries
  • Mini Mental Scores < 25

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dexamethasone, 0.1 mg/kgDexamethasone acetateThe patients in the Dexamethasone group get iv 0.1 mg/kg dexamethasone preoperative.
PlaceboPlaceboIn the Placebo group the patients get 0.1 ml/kg normal saline.
Primary Outcome Measures
NameTimeMethod
Visual analogue pain scale at rest and on movement postoperativelyPostoperative in recovery, 6, 12, 24, 48, 72 hourly
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cork University Hospital

🇮🇪

Cork, Ireland

© Copyright 2025. All Rights Reserved by MedPath